Although two recent studies have also reported a profound loss of pain sensation following administration of either a Nav1.7 blocking peptide from Centipede venom40, or an anti-Nav1.7 monoclonal antibody41, neither of these molecules were reported to induce facial lesions or anosmia. The gene discussed is SCN9A; the disease is Kallmann syndrome.